NovaBridge Biosciences (NBP) Form 6-K — Jun 29, 2026
NovaBridge Biosciences announced a significant executive transition, appointing Dr. Srishti Gupta as Chief Executive Officer and a member of the Board of Directors effective July 1, 2026. She succeeds Xi-Yong (Sean) Fu, who is stepping down from his roles as CEO and Director to pursue other opportunities, though he will support the company in an advisory capacity during the transition. Dr.
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.